Latest Lectins Stories
-- Patients with Thrombotic Microangiopathy Will Now Be Able to Receive Extended Treatment - SEATTLE, April 14, 2015 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced
Potential Human Immunogenicity Correlates Identified PRINCETON, N.J., March 11, 2015 /PRNewswire/ -- Soligenix, Inc.
PRINCETON, N.J., Sept. 19, 2014 /PRNewswire/ -- Soligenix, Inc.
Containers filled with several types of potentially deadly substances, including a nearly 100-year-old vial of the toxin ricin and samples of the pathogens that cause botulism and the plague, have reportedly been discovered at NIH and FDA laboratories.
All vaccinated animals exposed to a lethal aerosol of ricin toxin survive PRINCETON, N.J., Sept. 2, 2014 /PRNewswire/ -- Soligenix, Inc.
NEW YORK, Aug.
WAYNE, Pa., July 30, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP has commenced an investigation into potential
NEW YORK, July 30, 2014 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Galectin
-- Successful Phase 1 Results Set the Stage for Trials in Patients with Life-Threatening Blood Disorders -- SEATTLE, March 4, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER)
- An armed gangster.